Toloxatone

Toloxatone (Humoryl) is an antidepressant launched in 1984 in France for the treatment of depression. It acts as a selective reversible inhibitor of MAO-A (RIMA).[1]

Toloxatone

Clinical data
Routes of administration	Oral
ATC code	N06AG03 (WHO)
Legal status
Legal status	In general: uncontrolled
Identifiers
IUPAC name 5-(hydroxymethyl)-3-m-tolyloxazolidin-2-one
CAS Number	29218-27-7^N
PubChem CID	34521
ChemSpider	31769^Y
UNII	5T206015T5
KEGG	D02559^Y
ChEMBL	ChEMBL18116^Y
CompTox Dashboard (EPA)	DTXSID40865478
ECHA InfoCard	100.045.006
Chemical and physical data
Formula	C11H13NO3
Molar mass	207.229 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=C2OC(CO)CN2c1cccc(c1)C
InChI InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3^Y Key:MXUNKHLAEDCYJL-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

See also

• Befloxatone
• Cimoxatone

References

1. Berlin I, Zimmer R, Thiede HM, et al. (December 1990). "Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects". British Journal of Clinical Pharmacology. 30 (6): 805–16. doi:10.1111/j.1365-2125.1990.tb05445.x. PMC 1368300. PMID 1705137.